Cocrystal Pharma, Inc.

COCP · Nasdaq · SIC 2834: Pharmaceutical Preparations
351
SEC Filings

Business Summary

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel small molecule antiviral therapeutics for serious and chronic viral diseases caused by RNA viruses. Using proprietary structure-based drug design, X-ray crystallography, and computational chemistry guided by Nobel Prize-winning expertise, the company develops candidates targeting influenza virus, norovirus, coronaviruses (SARS-CoV-2, MERS-CoV), and hepatitis C virus (HCV), with lead programs including CC-42344 for influenza A.

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCOCPdiscussed_in_filing Cybersecurity
topic_mentionCOCPdiscussed_in_filing Trusted Computing
topic_mentionCOCPdiscussed_in_filing Blockchain & Crypto
topic_mentionCOCPdiscussed_in_filing Regulation
topic_mentionCOCPdiscussed_in_filing Healthcare & Bio
topic_mentionCOCPdiscussed_in_filing AI Compute
topic_mentionCOCPdiscussed_in_filing Platform & Ecosystem
topic_mentionCOCPdiscussed_in_filing Sovereign & Government
topic_mentionCOCPdiscussed_in_filing Cybersecurity
topic_mentionCOCPdiscussed_in_filing Trusted Computing
topic_mentionCOCPdiscussed_in_filing Blockchain & Crypto
topic_mentionCOCPdiscussed_in_filing Regulation
topic_mentionCOCPdiscussed_in_filing Healthcare & Bio
topic_mentionCOCPdiscussed_in_filing AI Compute
topic_mentionCOCPdiscussed_in_filing Platform & Ecosystem
topic_mentionCOCPdiscussed_in_filing Sovereign & Government
topic_mentionCOCPdiscussed_in_filing Cybersecurity
topic_mentionCOCPdiscussed_in_filing Trusted Computing
topic_mentionCOCPdiscussed_in_filing Blockchain & Crypto
topic_mentionCOCPdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-013838EDGAR53K words
2025-03-312024-12-310001641172-25-001496EDGAR—
2024-03-282023-12-310001493152-24-011613EDGAR—
2023-03-292022-12-310001493152-23-009385EDGAR—
2022-03-232021-12-310001493152-22-007551EDGAR—
2021-03-172020-12-310001493152-21-006211EDGAR—
2020-03-272019-12-310001493152-20-004916EDGAR—
2019-04-012018-12-310001493152-19-004386EDGAR—
2018-03-212017-12-310001493152-18-003708EDGAR—
2017-03-312016-12-310001493152-17-003110EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001493152-25-022581EDGAR16K words
2025-08-142025-06-300001641172-25-023728EDGAR—
2025-05-152025-03-310001641172-25-010539EDGAR—
2024-11-132024-09-300001493152-24-044978EDGAR—
2024-08-142024-06-300001493152-24-031877EDGAR—
2024-05-132024-03-310001493152-24-018787EDGAR—
2023-11-132023-09-300001493152-23-040322EDGAR—
2023-08-142023-06-300001493152-23-028046EDGAR—
2023-05-152023-03-310001493152-23-016927EDGAR—
2022-11-142022-09-300001493152-22-031622EDGAR—
2022-08-152022-06-300001493152-22-022597EDGAR—
2022-05-112022-03-310001493152-22-012782EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001493152-26-014819EDGAR1K words
2026-03-310001493152-26-013837EDGAR—
2026-03-130001493152-26-010071EDGAR—
2026-03-090001493152-26-009309EDGAR—
2026-02-190001493152-26-007430EDGAR—
2026-01-150001493152-26-002422EDGAR—
2025-12-180001493152-25-028296EDGAR—
2025-12-010001493152-25-025568EDGAR—
2025-11-140001493152-25-022603EDGAR—
2025-10-300001493152-25-020143EDGAR—

351 total filings indexed. 319 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

antiviral-therapeutics influenza-treatment-and-prophylaxis norovirus-treatment coronavirus-treatment hepatitis-c-virus-(hcv)-treatment structure-based-drug-design x-ray-crystallography computational-chemistry medicinal-chemistry molecular-modeling

Company Identity

CIK0001412486
TickerCOCP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d02a74b003f35866c9e42bde0b783db8d63377a845b04b6e225ad56f4021548d
parent: a9555de8b94855b49b985a3c442b5b35042cceacecd07e958512dcf411dfc627
content hash: 4d294e6922fa6162b0d05d80072a5062ffeb47ef6a201da844859dd21979af52
signed: 2026-04-13T04:44:25.608Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf